Guinea-Bissau vs Senegal: Share of people with HIV who receive antiretroviral therapy
Guinea-Bissau
79.0%
in 2024
Senegal
79.0%
in 2024
Guinea-Bissau rank
53rd
Senegal rank
53rd
Share of people with HIV who receive antiretroviral therapy over time
- Guinea-Bissau
- Senegal
How they compare
Guinea-Bissau currently reports 79.0% against 79.0% in Senegal, a difference of 0.0%.
Across all 25 years both countries report, Senegal has been ahead every year.
Guinea-Bissau ranks 53rd and Senegal ranks 53rd of 143 countries.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6% | 6.5% | 4.9% | Senegal |
| 2010s | 26.0% | 45.5% | 19.5% | Senegal |
| 2020s | 63.2% | 76.2% | 13.0% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Guinea-Bissau or Senegal?
- Guinea-Bissau, at 79.0% against 79.0% in Senegal as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Guinea-Bissau and Senegal?
- 0.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Senegal?
- 25 years are reported by both, from 2000 to 2024.
- How do Guinea-Bissau and Senegal rank globally for share of people with hiv who receive antiretroviral therapy?
- Guinea-Bissau ranks 53rd and Senegal ranks 53rd of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.